Osaka, Japan

Riko Nagahama

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Sumitomo Pharma Co., Ltd., Sumitomo Pharma Co., Ltd.. Active years: 2024-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Riko Nagahama. Retrieved from https://idiyas.com/inventor/riko-nagahama

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2024-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Riko Nagahama

Introduction

Riko Nagahama is an esteemed inventor based in Osaka, Japan, with a notable contribution to the field of pharmaceutical chemistry. He has developed innovative compounds that hold potential for various applications within the medical industry.

Latest Patents

Riko Nagahama is credited with one patent, which is a bicyclic pyridine derivative. The patent disclosure provides a detailed exploration of these bicyclic pyridine derivatives, particularly a compound represented by a specific formula. This invention may pave the way for new therapeutic options in pharmacology.

Career Highlights

Nagahama has made significant strides in his career while working at Sumitomo Pharma Co., Ltd., a respected company in the pharmaceutical sector. His work focuses on innovative research that enhances the company's portfolio of medicinal products. Through his expertise, he continues to contribute to advancements in health science.

Collaborations

In his journey, Riko Nagahama has collaborated with talented colleagues such as Satoshi Adachi and Hidefumi Yoshinaga. Together, they have worked on various projects that harness their shared knowledge and expertise, leading to meaningful contributions to the field.

Conclusion

Riko Nagahama's innovative work in the creation of bicyclic pyridine derivatives places him among noteworthy inventors in the pharmaceutical realm. His continued efforts at Sumitomo Pharma Co., Ltd. and collaborations with skilled professionals signify a commitment to advancing science and medicine. His singular patent reflects a promise for future developments in healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…